NZ196864A - Polymerisable dental composition containing a methacrylate monomer - Google Patents
Polymerisable dental composition containing a methacrylate monomerInfo
- Publication number
- NZ196864A NZ196864A NZ196864A NZ19686481A NZ196864A NZ 196864 A NZ196864 A NZ 196864A NZ 196864 A NZ196864 A NZ 196864A NZ 19686481 A NZ19686481 A NZ 19686481A NZ 196864 A NZ196864 A NZ 196864A
- Authority
- NZ
- New Zealand
- Prior art keywords
- monomer
- composition according
- thiourea
- weight
- cupric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/40—Redox systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dental Preparations (AREA)
Description
<div class="application article clearfix" id="description">
<p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number 1 96864 <br><br>
1CK c <br><br>
Priori • - *■'» t ■ ■, •• & ^ ■ ¥~ • $° <br><br>
• I i'Jt 3«. » 4—'•-.>*.-- • taciaiiaaaaaatata <br><br>
Compl^io G-p«csOcatjcn Filed: Lk^. Class: <br><br>
PubHczCon Date: . ,?.7. APR J984 <br><br>
P.O. Jaumzl, No: <br><br>
?l <br><br>
Patents Form No. 5 Number <br><br>
PATENTS ACT 1953 <br><br>
COMPLETE SPECIFICATION DENTAL COMPOSITIONS <br><br>
&We COLGATE-PALMOLIVE COMPANY of 300 Park Avenue, New York, N.Y.10022, United States of America, a company organised under the laws of the state of Delaware, United States of America do hereby declare the invention for which X/we pray that a Patent may be granted to uw^us, and the method by which it is to be performed, to be particularly described in and by the following statement: <br><br>
- 1 - <br><br>
1 <br><br>
if*N # <br><br>
10 <br><br>
15 <br><br>
20 <br><br>
25 <br><br>
The invention relates in general to polymerizable dental compositions and particularly to such compositions capable of undergoing a rapid rate of cure to produce a product polymerizate having a relatively higher quantity of insoluble component. <br><br>
Polymerizable dental compositions based on the use of methacrylate monomers, e.g. the reaction product of the bis glycidyl ether of bis phenol A and methacrylic acid (hereinafter designated BIS-GMA), are commonly used as fillings, pit and fissure sealants and are advantageously adapted to a wide variety of dental restorative techniques. Such compositions typically include one or more methacrylate monomers.and at least one component of a free radical liberating (redox) polymerization system for said monomer(s). Usually, the monomer composition so formulated includes the peroxy type catalyst (oxidant) which is later contacted with the reducing agent (reductant) shortly prior to dental use. Upon contact of the oxidant with the reductant compositions, usually for convenience provided as pastes, polymerization occurs leading to the formation of a polymerizate having the physical properties necessary to the maintenance of good structural integrity within the oral cavity, e.g. high compressive strength, high degree of insolubles, etc.. The latter condition is highly desirable to minimize leaching out of vital ingredients and consequent deterioration of the polymerizate. <br><br>
/■ <br><br>
I > <br><br>
I ! <br><br>
-2- <br><br>
Rapid and complete curing are thus highly desirable objectives. To some extent, increase in catalyst concentration enhances curing rate; however, correlative enhancement in the degree of cure does not necessarily obtain. In fact, it is often the case that large catalyst concentrations impair the degree of cure thus producing a relatively- larger percentage of soluble and leachable components in the final polymerizate. Moreover, larger amounts of peroxy catalyst increase the possibility of pre-polymerization of methacrylate monomer, i.e. prior to contact with reductant thereby often necessitating the use of adjuvants, often in unusually large amounts having a stabilizing or polymerization retardant effect. However, such retardant effects are inevitably manifest to some extent during monomer-oxidant-reductant contact thereby depressing the cure rate and, unavoidably the degree of cure. <br><br>
Accordingly the invention in its broader aspects provides a polymerizable dental composition and process for using samethe composition having an accelerated curing rate and high degree of cure comprising at least one methacrylate monomer having 2 to k polymerizable double bonds^ from about <br><br>
19-6S-8-4- <br><br>
0 to 400% by weight based on said monomer of inorganic particulate filler, from about 0 to 5% by weight based on said monomer of silane coupling agent, an effective catalyst - activating amount of accelerator comprising cupric ion and from about 0.5 to 5% by weight based on said monomer of compound selected from (a) free radical liberating polymerization catalyst comprising an organic peroxy compound, (b) reducing agent for said peroxy compound and (c) mixtures of (a) and (b), and wherein the concentration (b) does not exceed about 40% by weight of the total quantity of (a) and (b). <br><br>
Cupric ions are most conveniently supplied in the form of copper salts with organic and inorganic acids. Particularly preferred materials for use herein include, without necessary limitation, cupric acetate, cupric acetyl acetonate, cupric chloride, and cupric sulfate. The compounds may be used singly or in admixture comprising two or more. In addition, cuprous ion maybe present with the foregoing, although the cupric compounds are found to be generally more effective as regards the obtention of both high degree and rate of cure. Accordingly, it is particularly preferred herein that cupric ion Cu++, constitute at least about 50% of the total copper ion used. However, and as will be hereinafter demonstrated, the use of cuprous salts alone provides significant improvement when compared to test runs omitting entirely the copper ion. Whether this is due to the presence of cupric ions invariably present in available cuprous salts or to the cuprous ion or to the combination has not been clearly estab- <br><br>
ic," 4 <br><br>
I */ ^ - r <br><br>
The amount of co'pper ion present in the monomer composition is exceedingly small generally ranging from about 5 to 100 ppm preferably 8 to 50 ppm based on total monomer. Otherwise stated, the amount of copper ion is at least that necessary to provide effective catalyst activating or accelerating effects. The term "total monomer" as. used herein refers to the total monomer which would be present at the time polymerization actually occurs. Thus, in accordance with a preferred embodiment, peroxy catalyst, monomer and filler if used are included in a first paste composition referred to as the "oxidant" paste and the reducing agent -for '•said peroxy catalyst is included in a second "reductant" <br><br>
paste preferably including the same components as the first paste except for the peroxy catalyst. The pastes are mixed shortly prior to dental use whereupon polymerization is initiated The copper ion may be added to either or both of the paste j compositions with its presence in the oxidant composition being most preferred. In any event, copper ion concentration in this embodiment has reference to the total monomer present in both the oxidant and reductant pastes. On the basis of catalyst, the concentration of copper ion ranges from about 0.02 to 0.4$ of the peroxy compound. Generally, it is preferred to add the copper compound to the fluid monomer system (absent filler) which is intended as the oxidant paste. <br><br>
The copper compound can be added to the composition by dispensing same in the normally liquid monomer(s) component. <br><br>
The roqirl r;j l;<; <1 1 rip or o"! on onn bo achieved by addlnp 1;lio copper compound to the monomer as a solution in a solvent preferably a polar organic solvent; of low. hoi linn point such as ether or lower alkanol, e.g. methanol. Since the solvent is merely a carrier for the copper compound it is most desirable that it be of high volability so that generally, most if not all of the solvent is removed in subsequent handling operations, e.g. <br><br>
mixing, etc. The amount of solvent used is quite low, thus to provide 80 ppm Cu++, and using only a 1% solution in methanol, <br><br>
the volume of solvent would be only 12.5% of monomer volume and <br><br>
2.5% of a suitable paste on a weight basis. Alternatively, <br><br>
the copper compound may be sorbed onto the filler component, <br><br>
e.g. silica, should such material be used, for mixing with the monomer component(s). <br><br>
In addition to the copper compound, the preferred compositions herein are as follows: <br><br>
Parts by weight <br><br>
Monomer(s) 100 <br><br>
Inorganic particulate filler -0-100 <br><br>
t <br><br>
Silane coupling agent 0.5-5.0 <br><br>
Peroxy catalyst 0.5-5-0 <br><br>
Reducing agent 0.3-2.0 <br><br>
The methacrylate monomer is selected from materials having at least two, and preferably two to four polymerizable double bonds per molecule in order that the cured composite <br><br>
be crosslinked and thus better suited for use in the oral cavity. The most preferred monomers are those having two polymerizable double bonds per molecule. Desirable characteristics.for such monomers include low polymerization shrinkage, low exotherm during polymerization, low water sorption and the ability to cure rapidly and completely in the mouth. It is also desirable that the monomers be low In volatility and non-irritating to the tooth pulp. <br><br>
invention are those represented by the following general formulae: <br><br>
Methacrylate monomers particularly useful in this <br><br>
[ (M- A - 0)n - Ar ] - B <br><br>
(M - A - 0C0)2Ar <br><br>
I <br><br>
' II <br><br>
(M - A) CR <br><br>
M R 2 <br><br>
(M - A - 0C0 - NH)2R <br><br>
m <br><br>
III <br><br>
IV <br><br>
V <br><br>
CH <br><br>
CH <br><br>
CH <br><br>
M <br><br>
2 <br><br>
VI <br><br>
wherein M is methacryloyloxy, i.e. CH = C(CH )C00- ; <br><br>
2 3 <br><br>
M' is methacryloyloxy or hydroxyl; A is alkylene having 1-3 carbon atoms, such as methylene, propylene, isopropylene <br><br>
19686c hydrocyalkylene having 1-3 carbon atoms, such as hydroxy-methylene, 2-hydroxypropylene or acetoxyalkylene having 3-5 carbon atoms in the alkylene group such as 2-acetpxypropylene, 3-acetoxyamylene etc.; n is 1 to 1 preferably 1 or 2; m is 2 or 3 and p is 1 or 2 with the proviso that the sum of m and p is R is hydrogen, methyl, ethyl or -A-M wherein A and M are previously described; Ar is phenylene, e.g. o-phenylene, m-phenylene or p-phenylene, alkyl substituted phenylene, e.g. tolylene or 5-t-butyl-m-phenylene or cycloaliphatic having 6 to 10 carbon atoms such as 1,3-cyclohexylene; <br><br>
\ ^R <br><br>
B is . C . ^ wherein R and R are independently <br><br>
X \ u 5 <br><br>
X Vr5 <br><br>
hydrogen, alkyl e.g. to , or substituted alkyl and R' is alkylene having 2 to 12 carbon atoms such as ethylene, dodecylene etc., or -R^(O-R^) OR- wherein R^ is alkylene having 2 or 3 <br><br>
X <br><br>
carbon atoms such as ethylene, propylene or isopropylene and x is <br><br>
- 8 - <br><br>
2 0 OCT 1983 RECEIVED <br><br>
196864 <br><br>
zero to 5; and is phenylene, tolylene, methylene-bis-pheny-lene or alkylene having 2 to 12 carbon atoms. <br><br>
Monomers having the above formulae are well known and generally commercially available materials. Alternately, they are readily provided by conventional synthetic routes, for example, by reacting a phenolic compound such as diphenolic acid, phloroglucinol or bisphenol A with glycidyl methacrylate in the presence of various tertiary amines or by reacting methacrylic acid with an epoxide containing compound such as the diglycidyl ether of a bisphenol. Some of these monomers also are made by reacting appropriate alcohols with methacrylic acid, methacrylyl chloride or methacrylic anhydride. <br><br>
Illustrative monomers having these formulae include: <br><br>
CH2=C (CH3) COOCH2-OCO—^2y"COOCH2CH2OCOC (CH3) =CH2 <br><br>
C -fCH2OCOC (CH3) =CH214; <br><br>
CH-,CH_C i CH_0-C-C=CH„) ; <br><br>
J Z Z H I Z <br><br>
b ck3 <br><br>
CH2= C(CH3)COO(CH2)4OCOC(CH3)=CH2; <br><br>
CH2= C(CH3)COOCH2CH2OCH2CH2OCH2CH2OCOC(CH2)=CH2; <br><br>
CH2= C (CH3)COO— C (CH'3) —(^) O-COC (CH3)=CH2; <br><br>
CH2=C (CH3) COO-CH2CH (OH) CH9-O—^OCH0CH (OH)CH2OOOC(CH3)=CH2 <br><br>
CH2= C (CH3)COO-CH2CH2OCONH <br><br>
CH OCH2CH(OH)OCOC(CH3)=CH2 <br><br>
HCOOCH2CH2OCOC(CH3)=CH2 <br><br>
CH =C (CH.,) COO-CH-CH- 0CCNH-CHoCHoC-C--C-CHo—NHC00CH-CHo—CXX)-C (CHJ=CH0 <br><br>
Z J Z | Z Zi H | Z . Z Z <br><br>
CH CH CH CH i ■ <br><br>
*2. EXTENT OW** <br><br>
_9_ 2 0 OCT 1983 <br><br>
RECEIV'! <br><br>
19686,4- <br><br>
Monomers having the formulae I, III, III and IV are preferred in the practice of this invention. Of these monomers, I, II and III are particularly preferred, monomers IV being employed more often in admixture with one or more of monomers I, II and III. Further useful monomers comprise: <br><br>
Other useful methacrylate monomers suitable for use in the practice of this invention include those having the following formulae wherein M and Ar are as previously described; <br><br>
4 4 <br><br>
(MR OAr^CfCH^^ wherein R is ispropylene; <br><br>
(MR^OAr)2 and (MR^O)2Ar wherein R^ is 2-hydroxy- <br><br>
propylene; MA R^M wherein R^ is hydroxycyclopentyl or hydroxy- <br><br>
8 8 <br><br>
cyclohexyl, and A is 2-hydroxyethylene; and M2R wherein R is: <br><br>
(A) CH" <br><br>
s >-c-( s <br><br>
<B> ^ <br><br>
-CH2-(S)-CH2- <br><br>
CH2i§)"0i§^CH2- or <br><br>
(D> -ch2"<2^ch2- <br><br>
-10- <br><br>
HZ. PATENT pynca <br><br>
20 OCT 1983 <br><br>
RECEIVED <br><br>
1 9 <br><br>
^ /f o <br><br>
4 <br><br>
15 <br><br>
20 # <br><br>
Preparative? details .for many of those monomers are given in U.S. Patent Nos.3,066,112; 3,721,641; 3,730,9^7; 3,770,881 and 3,77') ,305. A tertiary outcctic monomer mixture also suitable for use in this invention is described in U.S. <br><br>
Patent No. 3,539,526. All of the aforementioned patents are herewith incorporated by reference in their entirety. <br><br>
It is to be understood that mixture of two or more appropriate methacrylate monomers are within the scope of this invention. In fact, depending on the choice of monomers, mixture are often highly desirable to optimize the characteristics of the resulting dental composition. <br><br>
Thus, it is preferred that the monomer or monomer blend have a viscosity of from about 100 to about 10,000 centi-poises as determined using a Brookfield viscometer at 20 rpm,at room temperature. <br><br>
The inorganic particulate filler employed in the compositions of this invention include fused silica, quartz, crystalline silica, amorphous silica, soda glass beads, <br><br>
glass rods, ceramic oxides, particulate silicate glass, radiopaque glasses(barium and strantium glasses), and synthetic minerals such as beta-eucryptic (LiAlSiO^), the latter having a negative coefficient of thermal expansion. It is also feasible to employ finely divided materials and powdered hydroxylapatite, although materials that react with silane coupling agents are preferred. Also available as a filler are colloidal or sub-rnicron silicas coated with a polymer. <br><br>
- 11 - <br><br>
1 <br><br>
5 <br><br>
.0 <br><br>
15 <br><br>
io <br><br>
25 <br><br>
Small amounts of pigments to allow matching of the composition to various shades of teeth can be included. Suitable pigments include iron oxide blacky cadmium yellows and oranges, fluorescent zinc oxides, titanium dioxide, etc.. The filler particles viould be generally smaller than about 50 microns in diameter and preferably smaller than 30 microns. It will be noted that the filler is an optional ingredient,unfilled formulations being employed where the dental composition is intended for use as a coating, malrgin sealant for amalgam restorations or adhesive. <br><br>
The silane coupling agents or keying agents are materials that contain at least one polymerizable double bond to react with the methacrylate monomers. Examples of suitable coupling agents are vinyl trichlorosilane, <br><br>
tris(acetoxy) vinyl silane, 1-N(vinylbenzylaminoethyl) aminopropyl trimethoxysilane-3 or 3-methacryloxypropyl trim-ethoxy silane. The last named1 Material is preferred for use with methacrylate monomers because of the similarity in reactivity of the double bonds. <br><br>
Peroxy catalysts useful herein and capable of initiating polymerization of the methacrylate monomer(s) <br><br>
are well known in the art for such use and include, without limitation, conventional peroxy as well as hydroperoxy compounds such as cumenc hydroperoxide, p-methane hydroperoxide, <br><br>
diisopropyl benzene hydroperoxide and t-butyl hydroperoxides. <br><br>
■ « <br><br>
- 12 - ' <br><br>
c <br><br>
Hydroperoxides are the preferred species of organic peroxy polymerization catalyst with cumene hydroperoxide (CIIP) <br><br>
being particularly preferred. If desired, peroxide stabilizers such as ascorbic acid, maleic acid and the like may be included in small amounts. <br><br>
Reducing agents useful herein generally include any material capable of reacting with the peroxy compound to form polymerization initiating, free radical species as is known in the art. Particularly useful herein is a substituted thiourea having the formula: <br><br>
i ll <br><br>
X N G Z <br><br>
wherein X is H or Y and Y is alkyl having 1 to 8 carbon atoms, such as methyl, butyl, octyl; cycloalkyl having 5 or 6 carbon atoms such as cyclopentyl, cyclohexyl; chloro, hydroxy or mercapto substituted alkyl having 1 to 8 carbon atoms such as"chloroethyl, mereapto-ethyl, hydroxymethyl and chlorooctyl; alkenyl having 3 to 4 carbon atoms, such as allyl or methallyl; aryl having 6 to 8 carbons, such as phenyl or xylyl, and chloro-, hydroxy-, methoxy-, or sulfonyl substituted phenyl such as chlorophenyl,.phenylsulfonyl, hydroxyphenyl and methoxyphenyl; acyl having 2 to 8 carbon atoms such as acetyljbutyry1, octanoylj chloro or methoxy substituted acyl, such as chloroacetyl, chlorobenzoyl, chlorotoluoyl and methoxybenzoyl; aralkyl having 7 to 8 carbon atoms, such <br><br>
- 13 - <br><br>
1 96 v • - - <br><br>
as benzyl, or chloro or methyl substituted aralkyl such as methoxybenzyl; and Z is NH^, NHX or NX . Examples of illustrative compounds suitable for use in the practice of this invention are methyl thiourea, isopropyl thiourea, <br><br>
butyl thiourea octyl thiourea, benzyl thiourea, acetyl thiourea, benzoyl thiourea, octanoyl thiourea, cyclohexyl thiourea, allyl thiourea, 1,1,3-triphenyl thiourea, 1,1,3-trimethyl thiourea, 2,4-xylyl thiourea, p-tolysulfony1 thiourea, l-octyl-3-phenyl thiourea, o-methoxyphenyl thiourea, m-hydroxyphenyl thiourea, 1,1-diallyl thiourea, 1,3-dially thiourea, 2-methallyl thiourea, o-methoxybenzyl thiourea, 1-(hydroxymethyl)-3-methyl thiourea, 1,1-dibutyl thiourea, 1,3-dibutyl thiourea, l-(p chloro phenyl)-3-methyl thiourea, 1 butyl-3-butyryl thiourea, l-acetyl-3-phenyl thiourea, 1 methyl-3-(p-vinylphenyl) thiourea, l-methyl-3-0 tolyl thiourea, l-methyl-3-pentyl thiourea, 3-methyl-l, 1-diphenyl thiourea and l-acetylr, 3-(2 metcaptoethyl) thiourea. While any of the aforementioned thioureas can be employed in the practice of this invention, preferred are the monosubstituted thioureas, that is, those having the aforementioned formula wherein X is H and Z is NH . Particularly preferred are i <br><br>
2 I <br><br>
phenyl thiourea, acetyl thiourea and allyl thiourea. Preferably the composition contains about 0.5 to about 1% by weight of reducing agent. <br><br>
The following examples are given for purposes of <br><br>
_ in _ <br><br>
) <br><br>
illustration only and are not to be considered as limiting the invention. <br><br>
EXAMPLES 1-14 Radiopaque reductant pastes having the following compositions are prepared: <br><br>
Ingredient 1NUPOL 2HMDMA 3A-174 <br><br>
Composition % by Weight j i <br><br>
ABCDEFGHj 10.27 10.24 10.27 10.27 10.27 10.27 10.27 10.2^ 10.27 10.24 10.27 10.27 10.27 10.27 10.27 10.2"/ 1.03 1.02 1.03 1.03 1.03 1.03 1.03' 1.0 <br><br>
Acetyl Thiourea 0.43 0.43 0.43 0.43 0.43 0.43 0.43 0.43 <br><br>
Ascorbic acid <br><br>
4 „ ++ <br><br>
Cu ; <br><br>
'Imsil A-10 <br><br>
0.07 <br><br>
-- .00022 .00044.0011 .0022 .0033-0044 <br><br>
41.86 41.86 41.86 41.86 41.86 41.86 41.86 41.86 <br><br>
'Corning 7724 TOTAL <br><br>
36.14 36.14 36.14 36.14 36.14 36.14 36.14 36.14 <br><br>
100 <br><br>
100 100 100 100 100 100 100; <br><br>
1 - Bis (GMA) <br><br>
2 - 1.6 hexanedioldimethacrylate <br><br>
3 <br><br>
^ * - z-methacryloxy propyl trimethoxy silane <br><br>
- In the form cupric acetate added from methanol solution to monomer mixture c. <br><br>
- Amorphous silica (Illinois Minerals) <br><br>
- Barium Glass (Corning) <br><br>
Radiopaque oxidant pastes having the following compositions arc prepared. <br><br>
Composition % by weight <br><br>
Ingredient Nupol HMDMA A - 17 4 <br><br>
Naleic acid : v Ascorbic, acid <br><br>
Cumene hydroperoxide (80$) <br><br>
Imsil A-10 Corning 7724 Total <br><br>
Oxidant and reductant pastes respectively are mixed in a weight ratio of 1:1 as indicated in the following examples. Curing times are given in minutes and include time required for mixing, approximately 30 seconds. The cessation of the curing reaction is determined by the material no longer being indentable by a spatula. It can also be done by measuring the percent of polymerizate insoluble in methanol upon completion of the curing reaction. Samples of the polymer-forming mass are taken at timed intervals during the curing reaction; cessation of the latter is indicated by the point at which percent insolubles remains substantially constant. The results are summarized as follows: <br><br>
I. <br><br>
9.94 9.94 0.99 <br><br>
0.07 1.05 41.93 36.06 <br><br>
100 <br><br>
.. Sk •- <br><br>
- 3-'--. . <br><br>
J <br><br>
9.78 9.78 0.98 <br><br>
0. .41 <br><br>
• •' <br><br>
1^0 5 <br><br>
41.79 36.22 100 <br><br>
- 16 - <br><br>
> <br><br>
1C ^ < <br><br>
4 \J v..' v,5 <br><br>
Example Oxidant Reductant PPM CU+*1' Cure Temp No. Paste Paste in Reductant Minutes on <br><br>
Paste <br><br>
1 <br><br>
J <br><br>
C <br><br>
2.2 <br><br>
3.5-4.3 <br><br>
21 <br><br>
2 <br><br>
II <br><br>
D <br><br>
4.4 <br><br>
2.8-3.2 <br><br>
23 <br><br>
3 <br><br>
II <br><br>
E . <br><br>
11.0 <br><br>
1.8-2.2 <br><br>
23 <br><br>
4 <br><br>
it <br><br>
F <br><br>
22.0 <br><br>
1.7-2.2 <br><br>
20.5 <br><br>
5 <br><br>
II <br><br>
G <br><br>
33.0 <br><br>
1.5-1.8 <br><br>
21.5 <br><br>
6 <br><br>
ii <br><br>
H <br><br>
44.0 <br><br>
1.3-1.8 <br><br>
23 <br><br>
7 <br><br>
it <br><br>
A <br><br>
none <br><br>
4.0-5.0 <br><br>
27 <br><br>
8 <br><br>
C <br><br>
2.2 <br><br>
3.3-3.8 <br><br>
21 <br><br>
9 <br><br>
II <br><br>
D <br><br>
4.4 <br><br>
2.7-3.5 <br><br>
22.5 <br><br>
10 <br><br>
II <br><br>
E <br><br>
11.0 <br><br>
1.8-2.2 <br><br>
23 <br><br>
11 <br><br>
tt <br><br>
F <br><br>
22.0 <br><br>
1.7-2.0 <br><br>
20.5 <br><br>
12 <br><br>
n <br><br>
G <br><br>
33.0 <br><br>
1.3-1.7 <br><br>
21 <br><br>
13 <br><br>
II <br><br>
Ii <br><br>
44.0 <br><br>
1.25-1.6 <br><br>
23 <br><br>
14 <br><br>
II <br><br>
A <br><br>
none <br><br>
3.3-4.0 <br><br>
21 <br><br>
In each of the runs, curing is carried out in air, i.e. in an open vessel. Increased concentration of Cu"1"* provides more rapid cures. <br><br>
- 17 - <br><br>
1 ~ 5 4 <br><br>
In comparison to Examples 7 and 14, which omit the copper accelerator, the data establish marked improvement in curing rate for the present invention. <br><br>
Similar combinations (1:1) of reductant paste B with I and J produce comparable results. <br><br>
EXAMPLES 15 ~ 17 <br><br>
The procedure of the foregoing examples is repeated but using a Nupol: HMDMA (71:29) by weight monomer blend in each of the oxidant and reductant compositions. <br><br>
Filler is omitted altogether in each of the examples. Copper ions are provided by the following compounds: <br><br>
Example No. Accelerator <br><br>
15 cupric acetate <br><br>
16 cupric chloride <br><br>
17 cupric acetonyl acetonate <br><br>
(no solvent) <br><br>
In each case, improved rate of curing is achieved when compared to identical control runs omitting the copper compound. <br><br>
18 - <br><br>
1 O < A <br><br>
» K J , ■ -}• <br><br>
EXAMPLES 18 - 20 <br><br>
The procedure of Examples 15-17 Is repeated but using the following materials as accelerators: <br><br>
The results are similar to those of the preceding examples. <br><br>
EXAMPLES 21 - 34 Each of examples 1-14 is repeated with the exception that the cupric acetate is sorbed onto the filler and then added to the monomer composition. Similar improvement is obtained in curing rate by comparison with control runs omitting the copper compound. <br><br>
EXAMPLES 35-37 <br><br>
The following reductant-containing and oxidant-containing compositions are prepared: <br><br>
Example No. <br><br>
Accelerator (weight ratios) <br><br>
20 <br><br>
18 <br><br>
19 <br><br>
cupric acetate/cupric chloride (50:50) cupric acetate/cuprous chloride (50:50) cupric chloride/cuprous chloride (50:50' <br><br>
- 19 - <br><br>
REDUCTANT <br><br>
Composition % by weight <br><br>
Ingredient <br><br>
NUPOL <br><br>
HMDMA <br><br>
Acetyl Thiourea Cu++ <br><br>
Corning 7724a IMSIL A-10a Colloidal Silica a. Silanized <br><br>
K <br><br>
9.9 9.9 0.45 0.0002 36.25 42.25 1.30 <br><br>
L <br><br>
9.9 9.9 0.45 <br><br>
0.0005 36.25 42.25 <br><br>
1. 30 <br><br>
M <br><br>
9.9 9.9 0.45 <br><br>
0.0010 <br><br>
36.25 <br><br>
42.25 <br><br>
1. 30 <br><br>
OXIDANT COMPOSITION - N <br><br>
Ingredient NUPOL HMDMA CHP (801) <br><br>
Corning 7724a IMSIL A-10a Colloidal Silica ai Silanized <br><br>
Composition % by weight 9.325 9.325 1.05 36.25 42.25 1. 80 <br><br>
The Oxidant paste is mixed on a clean glass plate with each of the three reductant pastes in a 1:1 ratio. Curing times for each of three mixes are determined by the <br><br>
- 20 - <br><br></p>
</div>
Claims (14)
1. A polymerizable dental composition having an accelerated curing rate comprising at least one methacrylate monomer having 2 to 4 polymerizable double bonds, from 0 to 400% by weight based on said monomer of inorganic particulate filler, from 0 to 5% by weight based on said monomer of silane coupling agent, an effective catalyst -activating amount of accelerator comprising cupric ion and from 0.5 to 5.0% by weight based on said monomer of compound selected from (a) free radical liberating polymerization catalyst comprising an organic peroxy compound, (b) reducing agent for said peroxy compound and (c) mixtures of (a) and (b), and wherein the concentration of (b) does not exceed 40% by weight of the total quantity of (a) and (b).<br><br>
2. A composition according to claim 1 wherein the ratio by weight of (a) to '(b) is 2:1.<br><br>
3. A composition according to claim 1 wherein said reducing agent is a substituted thiourea compound.<br><br>
4. A composition according to claim 3 wherein said reducing agent is an allyl or acetyl - substituted thiourea.<br><br>
5. A composition according to claim 4 wherein reducing agent is acetyl thiourea.<br><br> said peroxy compound is cumene hydropero><br><br> 22<br><br> 1 96684<br><br> (>.
A composition according t.o claim k wherein r.nlil peroxy compound is cumene hydroperoxide and .'Jaid reducing agent is allyl thiourea.<br><br>
7. A composition according to claim 1 wherein said cuprio ioti is present as cupric acetate, cupric acetyl acetonate, cupric chloride, or a mixture thereof.<br><br>
8. A composition according to claim 1 wherein the concentration of said cupric ion is from 5 to 100 ppm based on said monomer.<br><br>
9. A composition according to claim 1 wherein said cupric ion is dispersed in said monomer.<br><br>
10. A composition according to claim 1 wherein at least 40% by weight of said monomer comprises the reaction product; of glycidyl methacrylate and bisphenol A.<br><br>
11. A composition according to claim 10 wherein up to 60 /o by weight of said monomer is 1 ,6- hexanedioldimethacry-late.<br><br>
12. A composition according to claim 1 includi up to 50% bv weight based on the weight of cupric ion of , " -•<br><br> cuprous ion.<br><br> I i4DEfMQ«?<br><br> ng<br><br> -23-<br><br> \ \ ' V<br><br>
13. A composition according to claim 1 having a pat c -.1 ikc c on r. i r> t c nc y.<br><br>
14. A process for forming a dental polymerizate comprising contacting methacrylate monomer having 2 to 4 polymerizable double bonds with a redox polymerization catalyst capable of initiating the polymerization of said methacrylatc monomer and comprising organic3 peroxy compound and reducing agent therefor,said contacting being carried out in the presence of an effective catalyst activating amount of cupric ion.<br><br> WEST-WALKER, McCABE<br><br> per:<br><br> ATTORNEYS FSR-THE APPLICANT<br><br> -24-<br><br> </p> </div>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14519980A | 1980-04-29 | 1980-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ196864A true NZ196864A (en) | 1984-04-27 |
Family
ID=22512027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ196864A NZ196864A (en) | 1980-04-29 | 1981-04-16 | Polymerisable dental composition containing a methacrylate monomer |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS56169609A (en) |
AT (1) | AT376125B (en) |
AU (1) | AU554532B2 (en) |
BE (1) | BE888599A (en) |
BR (1) | BR8102607A (en) |
CA (1) | CA1223696A (en) |
CH (1) | CH649465A5 (en) |
DE (1) | DE3116132A1 (en) |
DK (1) | DK157727B (en) |
ES (1) | ES501695A0 (en) |
FR (1) | FR2481114A1 (en) |
GB (2) | GB2075035B (en) |
IE (1) | IE51152B1 (en) |
MX (1) | MX156002A (en) |
NL (1) | NL8102128A (en) |
NO (1) | NO158991C (en) |
NZ (1) | NZ196864A (en) |
PH (1) | PH17044A (en) |
SE (1) | SE450547B (en) |
ZA (1) | ZA812567B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3928987A1 (en) * | 1989-09-01 | 1991-03-28 | Siegfried Reiss | METHOD AND SHAPE FORM FOR PRODUCING SHAPINGS FOR THE DENTAL AREA |
DE4339399A1 (en) * | 1993-11-18 | 1995-05-24 | Thera Ges Fuer Patente | Dental inserts prodn. for use with composite filling materials. |
US20070100019A1 (en) * | 2005-08-02 | 2007-05-03 | Fuming Sun | Catalyst system for dental compositions |
DE102005039590B4 (en) * | 2005-08-19 | 2008-05-21 | Heraeus Kulzer Gmbh | Polymerizable dental composition with a 2-component initiator system |
EP1849449A1 (en) | 2006-04-26 | 2007-10-31 | 3M Innovative Properties Company | Filler containing composition and process for production and use thereof |
CA2685154C (en) * | 2007-04-25 | 2014-12-23 | Dentsply International Inc. | Self-adhesive dental cement having dual paste components |
JP2009292761A (en) * | 2008-06-04 | 2009-12-17 | Kuraray Medical Inc | Curable composition for dental use |
JP5388482B2 (en) * | 2008-06-04 | 2014-01-15 | クラレノリタケデンタル株式会社 | Dental curable composition |
CN102702405B (en) * | 2012-07-05 | 2014-04-09 | 东营市诺尔化工有限责任公司 | Method for preparing ultralow-residue water absorbing resins |
JP6112887B2 (en) * | 2013-02-05 | 2017-04-12 | 株式会社トクヤマデンタル | Dental curable composition |
JP6086797B2 (en) * | 2013-04-25 | 2017-03-01 | クラレノリタケデンタル株式会社 | Dental polymerizable composition |
WO2016007453A1 (en) | 2014-07-10 | 2016-01-14 | 3M Innovative Properties Company | Two-component self-adhesive dental composition, process of production and use thereof |
WO2016130441A1 (en) | 2015-02-09 | 2016-08-18 | Danville Materials, Llc | Dental compositions and methods of use |
KR102309461B1 (en) * | 2017-12-26 | 2021-10-05 | 가부시키가이샤 도쿠야마 덴탈 | Chemical polymerization initiator, adhesive composition, adhesive composition kit, dental material, dental material kit and storage method of adhesive composition |
EP3808324A1 (en) * | 2019-09-26 | 2021-04-21 | Shofu Inc. | Curable composition containing transition metal adsorbent |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB714868A (en) * | 1951-12-24 | 1954-09-01 | Dental Fillings Ltd | Improvements in or relating to polymerisation products |
GB1177879A (en) * | 1967-09-04 | 1970-01-14 | Sumitomo Chemical Co | Catalyst System and process for the Polymerisation of Vinyl Compounds |
JPS4842467B1 (en) * | 1970-12-04 | 1973-12-12 | ||
DE2420351B2 (en) * | 1973-04-26 | 1981-08-06 | National Patent Development Corp., New York, N.Y. | Tooth filling component |
JPS587646B2 (en) * | 1974-05-31 | 1983-02-10 | 東亞合成株式会社 | Niekiseikoukaseisoseibutsu |
JPS516224A (en) * | 1974-07-05 | 1976-01-19 | Johnson & Johnson | |
US3991008A (en) * | 1974-08-12 | 1976-11-09 | The Kendall Company | Dental compositions having improved color stability |
JPS51131197A (en) * | 1975-05-08 | 1976-11-15 | Sankin Ind Co | Uniiliquid type dental cement |
-
1981
- 1981-04-16 NZ NZ196864A patent/NZ196864A/en unknown
- 1981-04-16 ZA ZA00812567A patent/ZA812567B/en unknown
- 1981-04-23 DE DE19813116132 patent/DE3116132A1/en not_active Withdrawn
- 1981-04-27 AT AT0187781A patent/AT376125B/en not_active IP Right Cessation
- 1981-04-27 SE SE8102634A patent/SE450547B/en not_active IP Right Cessation
- 1981-04-28 NO NO811448A patent/NO158991C/en unknown
- 1981-04-28 BR BR8102607A patent/BR8102607A/en unknown
- 1981-04-28 PH PH25567A patent/PH17044A/en unknown
- 1981-04-28 ES ES501695A patent/ES501695A0/en active Granted
- 1981-04-28 BE BE0/204628A patent/BE888599A/en not_active IP Right Cessation
- 1981-04-28 FR FR8108413A patent/FR2481114A1/en active Granted
- 1981-04-28 CA CA000376461A patent/CA1223696A/en not_active Expired
- 1981-04-28 CH CH2760/81A patent/CH649465A5/en not_active IP Right Cessation
- 1981-04-28 AU AU69911/81A patent/AU554532B2/en not_active Ceased
- 1981-04-29 GB GB8113265A patent/GB2075035B/en not_active Expired
- 1981-04-29 MX MX187116A patent/MX156002A/en unknown
- 1981-04-29 NL NL8102128A patent/NL8102128A/en not_active Application Discontinuation
- 1981-04-29 IE IE958/81A patent/IE51152B1/en unknown
- 1981-04-29 DK DK189781A patent/DK157727B/en not_active Application Discontinuation
- 1981-04-30 JP JP6615881A patent/JPS56169609A/en active Pending
-
1983
- 1983-08-11 GB GB838321611A patent/GB8321611D0/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PH17044A (en) | 1984-05-17 |
ZA812567B (en) | 1982-11-24 |
IE810958L (en) | 1981-10-29 |
NO158991C (en) | 1988-11-23 |
DK189781A (en) | 1981-10-30 |
ATA187781A (en) | 1984-03-15 |
IE51152B1 (en) | 1986-10-15 |
CA1223696A (en) | 1987-06-30 |
NL8102128A (en) | 1981-11-16 |
MX156002A (en) | 1988-06-14 |
GB2075035A (en) | 1981-11-11 |
AU6991181A (en) | 1981-11-05 |
SE450547B (en) | 1987-07-06 |
NO811448L (en) | 1981-10-30 |
NO158991B (en) | 1988-08-15 |
AT376125B (en) | 1984-10-10 |
DK157727B (en) | 1990-02-12 |
ES8206560A1 (en) | 1982-08-16 |
ES501695A0 (en) | 1982-08-16 |
BE888599A (en) | 1981-08-17 |
AU554532B2 (en) | 1986-08-28 |
JPS56169609A (en) | 1981-12-26 |
GB8321611D0 (en) | 1983-09-14 |
FR2481114B1 (en) | 1984-11-30 |
GB2075035B (en) | 1984-07-25 |
BR8102607A (en) | 1982-01-19 |
FR2481114A1 (en) | 1981-10-30 |
CH649465A5 (en) | 1985-05-31 |
SE8102634L (en) | 1981-10-30 |
DE3116132A1 (en) | 1982-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3991008A (en) | Dental compositions having improved color stability | |
CA1076296A (en) | Photo-polymerizable dental restorative and tooth coating composition comprising an oligomeric resin, an acrylate monomer, an organic peroxide and a photosensitizer | |
US3066112A (en) | Dental filling material comprising vinyl silane treated fused silica and a binder consisting of the reaction product of bis phenol and glycidyl acrylate | |
NZ196864A (en) | Polymerisable dental composition containing a methacrylate monomer | |
US3751399A (en) | Polyacrylate resin compositions | |
US3194784A (en) | Silica-resin direct filling material and method of preparation | |
US4379695A (en) | Dental material comprising dimethyacrylate adducts of glycidyl methacrylate with diesters of bis(hydroxymethyl) tricyclo[5.2.1.02,6 ]decane and dicarboxylic acids | |
JPS59137404A (en) | Dental adhesive | |
EP0012535A1 (en) | Dental compositions comprising a selected vinyl urethane prepolymer and processes for their manufacture | |
JPS59140276A (en) | Novel adhesive | |
JPH0229104B2 (en) | ||
WO2005060920A1 (en) | One-pack type adhesive composition for dental use | |
JPH0776165B2 (en) | Dental restorative composition | |
US4774267A (en) | Dental material comprising adduct of glycidilmethacrylate and tricarboxylic acid | |
US3769336A (en) | Polyethylene glycol diacrylate | |
EP0295627B1 (en) | Photopolymerizable dental composition | |
US4337349A (en) | Dimethacrylate adducts of glycidyl methacrylate with diesters of bis (hydroxymethyl) tricyclo[5.2.1.02,6] decane and dicarboxylic acids | |
IE51153B1 (en) | Stabilization of methacrylate monomer compositions used in dental repair and restoration | |
JP3452613B2 (en) | Fluoride ion sustained release dental resin composition | |
US4831066A (en) | Dental compositions comprising oligomer of hexahydrophtalic anhydride, glycidylmethacrylate and 2-hydroxyethyl-methacrylate | |
JPS6011409A (en) | Dental material | |
JPS5869805A (en) | Composite material for dental use | |
JPH0378841B2 (en) | ||
JPS62281885A (en) | Phosphoryl compound and adhesive containing same | |
JPH0425247B2 (en) |